Sodium valproate and bone marrow suppression
- 1 August 1980
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 8 (2), 197-199
- https://doi.org/10.1002/ana.410080213
Abstract
Bone marrow suppression developed in a patient while she was on a regimen of sodium valproate. In addition, she had high titers of platelet autoantibodies and a coagulopathy, both recognized complications of valproate therapy. It is postulated that this drug was also responsible for the marrow suppression.Keywords
This publication has 7 references indexed in Scilit:
- Interaction between sodium valproate and platelets: a further study.BMJ, 1979
- Elevated Platelet-Associated IgG in the Thrombocytopenia of SepticemiaNew England Journal of Medicine, 1979
- Thrombocytopenia associated with sodium valproate treatmentAnnals of Neurology, 1979
- IgM platelet autoantibody due to sodium valproate.BMJ, 1978
- Sodium valproate and thrombocytopenia.BMJ, 1976
- Letter: Sodium valproate and platelet function.BMJ, 1976
- Sodium valproate and platelet function.BMJ, 1976